Minerva Labs
Minerva Labs is an Israeli private VC-backed cybersecurity startup focused on endpoint anti-evasion and preemptive ransomware disruption.
Visit WebsiteCompany Overview
Minerva Labs develops endpoint defense technology that targets evasive malware behavior and ransomware execution techniques before payload impact. Its approach emphasizes prevention against tactics designed to bypass conventional detection.
The company is privately held and venture-backed, with institutional financing supporting product development and market expansion. It is Israeli-founded and active in enterprise endpoint security segments.
Dual-use relevance is high: advanced endpoint malware prevention is essential for enterprise resilience and defense-adjacent environments where endpoint compromise can affect mission continuity.
Dual-Use Assessment
Endpoint anti-evasion and ransomware prevention are dual-use for commercial cyber defense and defense-adjacent operational continuity.
Key Technologies
- Endpoint anti-evasion protection layers
- Pre-execution ransomware disruption
- Malware behavior obfuscation detection
- Threat prevention policy controls
- Endpoint incident response telemetry support
Use Cases & Applications
- Preventing ransomware execution on enterprise endpoints
- Blocking evasive malware tactics in high-risk environments
- Hardening endpoint fleets in mission-adjacent organizations
- Reducing lateral movement opportunities from compromised workstations
- Improving resilience of distributed endpoint operations
Strategic Value to U.S.-Israel Alliance
Improves resilience against disruptive endpoint attacks that can halt critical operations.
Interested in this startup?
Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.